Research analysts at StockNews.com initiated coverage on shares of Global Indemnity Group (NASDAQ:GBLI – Get Free Report) in a report issued on Sunday. The firm set a “buy” rating on the insurance provider’s stock.
Global Indemnity Group Stock Down 1.4 %
Shares of GBLI opened at $35.63 on Friday. The business’s fifty day moving average is $35.69 and its 200 day moving average is $33.62. Global Indemnity Group has a 12-month low of $27.47 and a 12-month high of $37.00. The stock has a market cap of $487.79 million, a P/E ratio of 12.24 and a beta of 0.42.
Global Indemnity Group (NASDAQ:GBLI – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The insurance provider reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.41. The firm had revenue of $111.76 million for the quarter, compared to analyst estimates of $123.00 million. Global Indemnity Group had a net margin of 9.05% and a return on equity of 7.74%. During the same period last year, the firm earned ($0.05) earnings per share. On average, analysts expect that Global Indemnity Group will post 3.25 EPS for the current year.
Global Indemnity Group Company Profile
Global Indemnity Group, LLC, through its subsidiaries, provides specialty property and casualty insurance, and reinsurance products worldwide. It operates in two segments, Penn-America and Non-Core Operations. The company distributes property and general liability products for small commercial businesses through a network of wholesale general agents; and property and general liability niche products through program administrators with specific binding authority.
Read More
- Five stocks we like better than Global Indemnity Group
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Calculate Inflation Rate
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Most Volatile Stocks, What Investors Need to Know
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Global Indemnity Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Indemnity Group and related companies with MarketBeat.com's FREE daily email newsletter.